View Item 

Show simple item record

Multicentre retrospective study of intravascular large B‐cell lymphoma treated at academic institutions within the United States
dc.contributor.authorGeer, Marcus
dc.contributor.authorRoberts, Emily
dc.contributor.authorShango, Maryann
dc.contributor.authorTill, Brian G.
dc.contributor.authorSmith, Stephen D.
dc.contributor.authorAbbas, Hashim
dc.contributor.authorHill, Brian T.
dc.contributor.authorKaplan, Jason
dc.contributor.authorBarr, Paul M.
dc.contributor.authorCaimi, Paolo
dc.contributor.authorStephens, Deborah M.
dc.contributor.authorLin, Emily
dc.contributor.authorHerrera, Alex F.
dc.contributor.authorRosenbaum, Evan
dc.contributor.authorAmengual, Jennifer E.
dc.contributor.authorBoonstra, Philip S.
dc.contributor.authorDevata, Sumana
dc.contributor.authorWilcox, Ryan A.
dc.contributor.authorKaminski, Mark S.
dc.contributor.authorPhillips, Tycel J.
dc.date.accessioned2019-07-03T19:55:54Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2019-07-03T19:55:54Z
dc.date.issued2019-07
dc.identifier.citationGeer, Marcus; Roberts, Emily; Shango, Maryann; Till, Brian G.; Smith, Stephen D.; Abbas, Hashim; Hill, Brian T.; Kaplan, Jason; Barr, Paul M.; Caimi, Paolo; Stephens, Deborah M.; Lin, Emily; Herrera, Alex F.; Rosenbaum, Evan; Amengual, Jennifer E.; Boonstra, Philip S.; Devata, Sumana; Wilcox, Ryan A.; Kaminski, Mark S.; Phillips, Tycel J. (2019). "Multicentre retrospective study of intravascular large B‐cell lymphoma treated at academic institutions within the United States." British Journal of Haematology 186(2): 255-262.
dc.identifier.issn0007-1048
dc.identifier.issn1365-2141
dc.identifier.urihttps://hdl.handle.net/2027.42/149677
dc.publisherR Foundation for Statistical Computing
dc.publisherWiley Periodicals, Inc.
dc.subject.otherB cells
dc.subject.otherlymphomas
dc.subject.otherdiagnostic haematology
dc.titleMulticentre retrospective study of intravascular large B‐cell lymphoma treated at academic institutions within the United States
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/149677/1/bjh15923.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/149677/2/bjh15923_am.pdf
dc.identifier.doi10.1111/bjh.15923
dc.identifier.sourceBritish Journal of Haematology
dc.identifier.citedreferenceDetsky, M.E., Chiu, L., Shandling, M.R., Sproule, M.E. & Ursell, M.R. ( 2006 ) Clinical problem‐solving. Heading down the wrong path. New England Journal of Medicine, 355, 67 – 74.
dc.identifier.citedreferenceBrunet, V., Marouan, S., Routy, J.P., Amin Hashem, M., Bernier, V., Simard, R., Petrella, T., Lamarre, L., Theoret, G., Carrier, C., Knecht, H., Fleury, I. & Pavic, M. ( 2017 ) Retrospective study of intravascular large B‐cell lymphoma cases diagnosed in Quebec: a retrospective study of 29 case reports. Medicine (Baltimore), 96, e5985.
dc.identifier.citedreferenceShimada, K., Matsue, K., Yamamoto, K., Murase, T., Ichikawa, N., Okamoto, M., Niitsu, N., Kosugi, H., Tsukamoto, N., Miwa, H., Asaoku, H., Kikuchi, A., Matsumoto, M., Saburi, Y., Masaki, Y., Yamaguchi, M., Nakamura, S., Naoe, T. & Kinoshita, T. ( 2008 ) Retrospective analysis of intravascular large B‐cell lymphoma treated with rituximab‐containing chemotherapy as reported by the IVL study group in Japan. Journal of Clinical Oncology, 26, 3189 – 3195.
dc.identifier.citedreferenceRosenberg, S.A. ( 1977 ) Validity of the Ann Arbor staging classification for the non‐Hodgkin’s lymphomas. Cancer Treatment Reports, 61, 1023 – 1027.
dc.identifier.citedreferenceHans, C.P., Weisenburger, D.D., Greiner, T.C., Gascoyne, R.D., Delabie, J., Ott, G., Müller‐Hermelink, H.K., Campo, E., Braziel, R.M., Jaffe, E.S., Pan, Z., Farinha, P., Smith, L.M., Falini, B., Banham, A.H., Rosenwald, A., Staudt, L.M., Connors, J.M., Armitage, J.O. & Chan, W.C. ( 2004 ) Confirmation of the molecular classification of diffuse large B‐cell lymphoma by immunohistochemistry using a tissue microarray. Blood, 103, 275 – 282.
dc.identifier.citedreferenceFerreri, A.J., Dognini, G.P., Govi, S., Crocchiolo, R., Bouzani, M., Bollinger, C.R., D’Incan, M., Delaporte, E., Hamadani, M., Jardin, F., Martusewicz‐Boros, M., Montanari, M., Szomor, A., Zucca, E., Cavalli, F. & Ponzoni, M. ( 2008 ) Can rituximab change the usually dismal prognosis of patients with intravascular large B‐cell lymphoma? Journal of Clinical Oncology, 26, 5134 – 5136.
dc.identifier.citedreferenceFerreri, A.J., Campo, E., Seymour, J.F., Willemze, R., Ilariucci, F., Ambrosetti, A., Zucca, E., Rossi, G., Lopez‐Guillermo, A., Pavlovsky, M.A., Geerts, M.L., Candoni, A., Lestani, M., Asioli, S., Milani, M., Piris, M.A., Pileri, S., Facchetti, F., Cavalli, F. & Ponzoni, M.; Internal Extranodal Lymphoma Study Group (IELSG). ( 2004 ) Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’. British Journal of Haematology, 127, 173 – 183.
dc.identifier.citedreferenceDiGiuseppe, J.A., Nelson, W.G., Seifter, E.J., Boitnott, J.K. & Mann, R.B. ( 1994 ) Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. Journal of Clinical Oncology, 12, 2573 – 2579.
dc.identifier.citedreferenceSuehara, Y., Sakata‐Yanagimoto, M., Hattori, K., Abe, Y., Narita, K., Takeuchi, M., Matsue, K., Itoh, T., Kaji, D., Yamamoto, G., Nanmoku, T., Baba, N., Kusakabe, M., Sakamoto, T., Kurita, N., Yokoyama, Y., Nishikii, H., Hasegawa, Y., Obara, N. & Chiba, S. ( 2017 ) Liquid biopsy for the identification of intravascular large B‐cell lymphoma. Blood, 130, 378.
dc.identifier.citedreferenceRoschewski, M., Dunleavy, K., Pittaluga, S., Moorhead, M., Pepin, F., Kong, K., Shovlin, M., Jaffe, E.S., Staudt, L.M., Lai, C., Steinberg, S.M., Chen, C.C., Zheng, J., Willis, T.D., Faham, M. & Wilson, W.H. ( 2015 ) Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B‐cell lymphoma: a correlative biomarker study. Lancet Oncology, 16, 541 – 549.
dc.identifier.citedreferenceRoschewski, M. ( 2015 ) Monitoring lymphoma patients after therapy. Clinical Advances in Hematology and Oncology, 5, 277 – 279.
dc.identifier.citedreferenceRöglin, J. & Böer, A. ( 2007 ) Skin manifestations of intravascular lymphoma mimic inflammatory diseases of the skin. British Journal of Dermatology, 157, 16 – 25.
dc.identifier.citedreferenceRajyaguru, D.J., Bhaskar, C., Borgert, A.J., Smith, A. & Parsons, B. ( 2016 ) Intravascular large B cell lymphoma in the United States (US): a population‐ based study using Surveillance, Epidemiology, and End Results Program and National Cancer Data Base. Blood, 128, 1114.
dc.identifier.citedreferenceR Core Team. ( 2018 ) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, https://www.R-project.org/.
dc.identifier.citedreferencePfleger, L. & Tappeiner, J. ( 1959 ) On the recognition of systematized endotheliomatosis of the cutaneous blood vessels (reticuloendotheliosis). Hautarzt, 10, 359 – 363.
dc.identifier.citedreferenceMurase, T., Yamaguchi, M., Suzuki, R., Okamoto, M., Sato, Y., Tamaru, J., Kojima, M., Miura, I., Mori, N., Yoshino, T. & Nakamura, S. ( 2007 ) Intravascular large B‐cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood, 109, 478 – 485.
dc.identifier.citedreferenceMurase, T., Nakamura, S., Kawauchi, K., Matsuzaki, H., Sakai, C., Inaba, T., Nasu, K., Tashiro, K., Suchi, T. & Saito, H. ( 2000 ) An Asian variant of intravascular large B‐cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B‐cell lymphoma associated with haemophagocytic syndrome. British Journal of Haematology, 111, 826 – 834.
dc.identifier.citedreferenceMurase, T., Nakamura, S., Tashiro, K., Suchi, T., Hiraga, J., Hayasaki, N., Kimura, M., Murakami, M., Mizoguchi, Y., Suzuki, T. & Saito, H. ( 1997 ) Malignant histiocytosis‐like B‐cell lymphoma, a distinct pathologic variant of intravascular lymphomatosis: a report of five cases and review of the literature. British Journal of Haematology, 99, 656 – 664.
dc.identifier.citedreferenceMoormeier, J.A., Williams, S.F. & Golomb, H.M. ( 1990 ) The staging of non‐Hodgkin’s lymphomas. Seminars in Oncology, 17, 43 – 50.
dc.identifier.citedreferenceKurtz, D.M., Green, M.R., Bratman, S.V., Scherer, F., Liu, C.L., Kunder, C.A., Takahashi, K., Glover, C., Keane, C., Kihira, S., Visser, B., Callahan, J., Kong, K.A., Faham, M., Corbelli, K.S., Miklos, D., Advani, R.H., Levy, R., Hicks, R.J., Hertzberg, M., Ohgami, R.S., Gandhi, M.K., Diehn, M. & Alizadeh, A.A. ( 2015 ) Noninvasive monitoring of diffuse large B‐cell lymphoma by immunoglobulin high‐throughput sequencing. Blood, 125, 3679 – 3687.
dc.identifier.citedreferenceHowlader, N., Noone, A.M., Krapcho, M., Miller, D., Brest, A., Yu, M., Ruhl, J., Tatalovich, Z., Mariotto, A., Lewis, D.R., Chen, H.S., Feuer, E.J., & Cronin, K.A. (eds.). ( 2018 ) Contents of SEER Cancer Statistics Review (1975–2016), National Cancer Institute, DCCPS, released April 2018 based on November 2017 submission.
dc.identifier.citedreferenceHong, J.Y., Kim, H.J., Ko, Y.H., Choi, J.Y., Jung, C.W., Kim, S.J. & Kim, W.S. ( 2013 ) Clinical features and treatment outcomes of intravascular large B‐cell lymphoma: a single‐center experience in Korea. Acta Hematologica, 131, 18 – 27.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
bjh15923.pdf
Size:
187.1KB
Format:
PDF
View/Open
Name:
bjh15923_am.pdf
Size:
221.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.